Key points from article :
Immorta Bio, led by stem cell expert Dr. Thomas Ichim, is working on personalized cellular therapies to treat cancer and liver failure. These therapies use the body’s own immune and stem cells to repair damaged tissues and fight disease, rather than relying only on medications or surgery. Dr. Ichim has decades of experience in biotechnology and focuses on how aging weakens the immune system, making people more vulnerable to serious illnesses. His team is designing treatments that are tailored to each person’s biology, increasing the chances of success and reducing harmful side effects.
The research explores how to reprogram immune cells to better target cancer or restore function in failing organs like the liver. This isn’t just about treating symptoms but helping the body heal from within. These cell-based approaches are still being studied but show real promise in early results. Immorta Bio’s work is part of a growing field that sees potential in using living cells as medicine. If successful, these treatments could shift how we handle age-related diseases in the future, offering new hope to patients who currently have limited options. The company continues to refine these methods through ongoing clinical research and testing.
